China Shineway Pharmaceutical Group Limited (FRA:C1S)

Germany flag Germany · Delayed Price · Currency is EUR
0.8800
+0.0050 (0.57%)
Last updated: Sep 29, 2025, 3:29 PM CET
0.57%
Market Cap692.59M
Revenue (ttm)397.48M
Net Income (ttm)98.45M
Shares Outn/a
EPS (ttm)0.13
PE Ratio7.04
Forward PE6.97
Dividend0.06 (6.47%)
Ex-Dividend DateSep 9, 2025
Volumen/a
Average Volume1,114
Open0.8900
Previous Close0.8750
Day's Range0.8800 - 0.8900
52-Week Range0.7850 - 1.2600
Betan/a
RSI43.36
Earnings DateNov 27, 2025

About FRA:C1S

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, ortho... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 3,220
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C1S
Full Company Profile

Financial Performance

In 2024, FRA:C1S's revenue was 3.78 billion, a decrease of -16.35% compared to the previous year's 4.52 billion. Earnings were 840.05 million, a decrease of -13.35%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.